ClearBridge Investments’s Myriad Genetics MYGN Stock Holding History

ClearBridge Investments’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,376	Closed	-$20K	–	1023
2020 Q1	$20K	Sell	1,376 -40	-3%	-$845	﹤0.01%	880
2019 Q4	$39K	Sell	1,416 -1	-0.1%	-$28	﹤0.01%	861
2019 Q3	$41K	Sell	1,417 -15	-1%	-$437	﹤0.01%	842
2019 Q2	$40K	Sell	1,432 -5	-0.3%	-$141	﹤0.01%	839
2019 Q1	$48K	Sell	1,437 -7	-0.5%	-$213	﹤0.01%	839
2018 Q4	$42K	Buy	1,444 +19	+1%	+$684	﹤0.01%	864
2018 Q3	$66K	Sell	1,425 -5	-0.3%	-$222	﹤0.01%	868
2018 Q2	$53K	Sell	1,430 -7	-0.5%	-$236	﹤0.01%	844
2018 Q1	$42K	Hold	1,437	–	–	﹤0.01%	870
2017 Q4	$49K	Buy	1,437 +5	+0.3%	+$169	﹤0.01%	849
2017 Q3	$52K	Buy	1,432 +43	+3%	+$1.23K	﹤0.01%	843
2017 Q2	$36K	Buy	+1,389	New	+$29.5K	﹤0.01%	909
2015 Q3	–	Sell	-50	Closed	-$2K	–	1194
2015 Q2	$2K	Buy	+50	New	+$1.7K	﹤0.01%	1144
2015 Q1	–	Sell	-50	Closed	-$2K	–	1191
2014 Q4	$2K	Buy	+50	New	+$1.77K	﹤0.01%	1162

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments's MYGN Position: Q2 2020 in Review

ClearBridge Investments sold out of Myriad Genetics (MYGN) in Q2 2020, closing a stake of 1,376 shares — an estimated $20K sold.

ClearBridge Investments first reported a position in MYGN in Q4 2014 and held it in 14 quarters. The position peaked at $66K in Q3 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2020.

ClearBridge Investments reported no remaining Myriad Genetics position as of Q2 2020 after selling out during the quarter.
ClearBridge Investments sold 1,376 Myriad Genetics shares in Q2 2020, an estimated $20K.
ClearBridge Investments first reported a position in Myriad Genetics in Q4 2014 and held it in 14 quarters.
ClearBridge Investments's Myriad Genetics position peaked at $66K in Q3 2018.
196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2020.

Based on ClearBridge Investments's 13F filing for Q2 2020, filed 14 Aug 2020.